Insulin receptor activity (tyrosine kinase) also decreases simultaneously, leading to structural or functional defects in various enzymes in the glucose metabolic pathway (e.g., glucokinase) and impaired glucose metabolism in the body, which results in insulin resistance and IGF-1 deficiency. The gene discussed is IGF1; the disease is Insulin resistance.